| Eileen Jacobson, | |
|
735 E 1400 N, Mapleton, UT 84664-3850 | |
| (801) 367-5222 | |
| Not Available |
| Full Name | Eileen Jacobson |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 735 E 1400 N, Mapleton, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700278389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 1171043902 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eileen Jacobson, 735 E 1400 N, Mapleton, UT 84664-3850 Ph: (801) 367-5222 | Eileen Jacobson, 735 E 1400 N, Mapleton, UT 84664-3850 Ph: (801) 367-5222 |
News Archive
One change to field triage guidelines for emergency medical services responding to older adults with head trauma could make a "clinically important improvement over usual care," according to a study and accompanying editorial published earlier this month in Annals of Emergency Medicine ("Out-of-Hospital Triage of Older Adults With Head Injury: A Retrospective Study of the Effect of Adding 'Anticoagulation or Antiplatelet Medication Use' as a Criterion" and "Can an Out-of-Hospital Medication History Save Lives for Injured Older Adults?").
One of the biggest questions about the treatment of multiple myeloma, a form of blood cancer, is why nearly all patients treated with current therapies eventually suffer relapse. A Yale Cancer Center study may have solved this mystery by identifying how cancer cells escape treatment, leading to recurrence.
Silence Therapeutics plc today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in August 2009, the companies are leveraging Silence's proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate functional delivery of RNA interference (RNAi) therapeutics to specific disease targets in the body.
Despite a backdrop of declining rates, a new study concludes cervical cancer continues to be a more serious threat to women with low incomes and educational levels.
Increasing access. Improving quality and efficiency. Lowering costs. When GE launched its healthymagination initiative last year, these were the long-term goals and at RSNA 2010, GE Healthcare will highlight a variety of technologies developed to support this strategy and help improve patient care worldwide.
› Verified 4 days ago
Summer Simmons, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 704 S 1600 W Ste 104, Mapleton, UT 84664 Phone: 801-491-6394 Fax: 801-491-6613 | |
Skyler Elden Clark, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 774 S 1600 W Ste 101, Mapleton, UT 84664 Phone: 801-407-4134 Fax: 801-877-0684 |